The U.S. National Institutes of Health (NIH) recently established a pandemic preparedness research network to research high-priority pathogens most likely to threaten human health to develop effective vaccines and monoclonal antibodies.
The Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness network (ReVAMPP) will focus its research efforts on “prototype pathogens,” representative pathogens from virus families known to infect humans, and high-priority pathogens that have the potential to cause deadly diseases.
Read More
